PMID- 10433944 OWN - NLM STAT- MEDLINE DCOM- 19990831 LR - 20181113 IS - 0002-9440 (Print) IS - 0002-9440 (Linking) VI - 155 IP - 2 DP - 1999 Aug TI - Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. PG - 517-26 AB - Germline mutations of c-met oncogene at 7q31 have been detected in patients with hereditary papillary renal cell carcinoma. In addition, c-met mutations were shown to play a role in 13% of patients with papillary renal cell carcinoma and no family history of renal tumors. The histopathology of papillary renal cell carcinoma with c-met mutations has not been previously described. We analyzed the histopathology of 103 bilateral archival papillary renal cell carcinomas and 4 metastases in 29 patients from 6 hereditary papillary renal cell carcinoma families with germline c-met mutations and 6 papillary renal cell carcinomas with c-met mutations from 5 patients with no family history of renal tumors. Twenty-five sporadic renal tumors with prominent papillary architecture and without somatic c-met mutations were evaluated for comparison. All papillary renal cell carcinomas with c-met mutations were 75 to 100% papillary/tubulopapillary in architecture and showed chromophil basophilic, papillary renal cell carcinoma type 1 histology. Fuhrman nuclear grade 1-2 was seen in tumors from 23 patients, and nuclear grade 3 was observed focally in 8 patients. Seventeen patients had multiple papillary adenomas and microscopic papillary lesions in the surrounding renal parenchyma. Clear cells with intracytoplasmic lipid and glycogen were focally present in tumors of 94% papillary renal cell carcinoma patients. Clear cells of papillary renal cell carcinoma had small basophilic nuclei, and clear cell areas lacked a fine vascular network characteristic of conventional (clear) cell renal cell carcinoma. We conclude that papillary renal cell carcinoma patients with c-met mutations develop multiple, bilateral, papillary macroscopic and microscopic renal lesions. Renal tumors with c-met genotype show a distinctive papillary renal cell carcinoma type 1 phenotype and are genetically and histologically different from renal tumors seen in other hereditary renal syndromes and most sporadic renal tumors with papillary architecture. Although all hereditary and sporadic papillary renal cell carcinomas with c-met mutations share papillary renal cell carcinoma type 1 histology, not all type 1 sporadic papillary renal cell carcinomas harbor c-met mutations. FAU - Lubensky, I A AU - Lubensky IA AD - Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA. lubensky@box-l.nih.gov FAU - Schmidt, L AU - Schmidt L FAU - Zhuang, Z AU - Zhuang Z FAU - Weirich, G AU - Weirich G FAU - Pack, S AU - Pack S FAU - Zambrano, N AU - Zambrano N FAU - Walther, M M AU - Walther MM FAU - Choyke, P AU - Choyke P FAU - Linehan, W M AU - Linehan WM FAU - Zbar, B AU - Zbar B LA - eng GR - N01-CO-56000/CO/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - EC 2.7.10.1 (Proto-Oncogene Proteins c-met) SB - IM MH - Adenoma/genetics/pathology MH - Adult MH - Aged MH - Carcinoma, Papillary/*genetics/*pathology MH - Chromosomes, Human, Pair 7 MH - Family Health MH - Female MH - *Germ-Line Mutation MH - Humans MH - Kidney Neoplasms/*genetics/*pathology MH - Male MH - Middle Aged MH - Neoplasm Metastasis MH - Pedigree MH - Phenotype MH - Proto-Oncogene Proteins c-met/*genetics/metabolism MH - Trisomy PMC - PMC1866853 EDAT- 1999/08/06 00:00 MHDA- 1999/08/06 00:01 CRDT- 1999/08/06 00:00 PHST- 1999/08/06 00:00 [pubmed] PHST- 1999/08/06 00:01 [medline] PHST- 1999/08/06 00:00 [entrez] AID - S0002-9440(10)65147-4 [pii] AID - 10.1016/S0002-9440(10)65147-4 [doi] PST - ppublish SO - Am J Pathol. 1999 Aug;155(2):517-26. doi: 10.1016/S0002-9440(10)65147-4.